% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

dmokeson 6 posts  |  Last Activity: 1 hour 0 minutes ago Member since: Jan 6, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    COMON Meow BOY alias DUMMY .

    by eddiebuttles Apr 23, 2015 9:43 AM
    dmokeson dmokeson 1 hour 0 minutes ago Flag

    Hey BUTTS! Take a VERY slow boat to China, and get off of this board. Thanks in advance.

  • Reply to

    Earnings coming soon

    by svchiro Apr 20, 2015 4:40 PM
    dmokeson dmokeson Apr 21, 2015 9:55 AM Flag

    They have to get a real good industry insider to help with partnerships. I believe they have so much good going on,but they don't know what to do or who to talk to.

  • Reply to

    A new topic

    by dmokeson Mar 22, 2015 8:46 PM
    dmokeson dmokeson Mar 24, 2015 2:08 PM Flag

    They already did an offering in Feb. raising 79.1 million, they go the full lunch second week of April they should bring in at least $400 to $ 500 million in the first 12 month period. Remember there is no other drug of this class and if they get 80% of the market their gross rev. will be about $1.42 BILLION

  • dmokeson by dmokeson Mar 22, 2015 8:46 PM Flag

    well falmal is almost $18 I've been here since $7 , up and down ok , with the law suite holding SB down for two years and I don't see to much more of a large mover, you guys ( mr Cheerio , the great bar tender of the east pub and Eddie buttes). I'd like to tell you all about an eye and more company. Omeras , they have an FDA approve eye treatment for lenses implants and cadoracts one application and done. If you go to thier web site you will get all the info. But I have done the numbers for you. 37,400,000 shares outstanding, 4,000,000 operations in the US yearly the Feds have all ready approved CMS cost pay back to the doctors of $465.00 per eye plus 6 per cent handling fee. Mutlopile that out and take 80 per of the patient number (3,200,000) and you come up with 1,400,000,000 in annual sale , divide that at 37.4 and you get a neet $40 buckes a share , if current P/E runs 17 times earnings , you got a Regerron Company. You are looking at $400 plus per share , now check the Compauy out and you see a pipeline that got a lot going on. They launch thier new drug second week of Aprial.Their FDA is good for 7 years , they expect to hav EU approve with in 6 months. Boys I'm a 70 year old guy #$%$ this for 40 years , this could be the best company I have come accross since Regrerron. Tomorrow I'm sell a good porition of my Flamal and betting on the NEW EYE guy. Good luck to all of you and I sure have had some fun reading all the stories form the bartender. DMOKESON

  • Reply to

    EPS Revised up Thursday, Friday..

    by eddiebuttles Mar 22, 2015 10:44 AM
    dmokeson dmokeson Mar 22, 2015 11:31 AM Flag

    anybody that reads a Zack's report or the ratings of a company by Zacks is not a investor. They are trash!

  • dmokeson by dmokeson Jan 30, 2015 10:51 AM Flag

    To much GOOD than bad ,We are going to be bought and most likely sooner than not.

2.69-0.28(-9.43%)Apr 24 4:00 PMEDT